Melatonin signaling in mouse cerebellar granule cells with variable native MT1 and MT2 melatonin receptors

Brain Research

Volumn 1227, Issue , 2008, Pages 19-25

  Imbesi, Marta ^a   Uz, Tolga ^a   Dzitoyeva, Svetlana ^a   Giusti, Pietro ^b   Manev, Hari ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Akt; Cerebellar; ERK; Melatonin; MT1; MT2

Indexed keywords

CYCLIC AMP; FORSKOLIN; G PROTEIN COUPLED RECEPTOR; MELATONIN; MELATONIN 1 RECEPTOR; MELATONIN 2 RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN C FOS; PROTEIN KINASE B; PROTEIN SERINE THREONINE KINASE;

ANIMAL CELL; ARTICLE; BRAIN CELL; CELL CULTURE; CEREBELLUM; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; GRANULE CELL; IMMUNOREACTIVITY; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; BLOTTING, WESTERN; CELLS, CULTURED; CEREBELLUM; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; IMMUNOHISTOCHEMISTRY; MELATONIN; MICE; MICE, INBRED C3H; MICE, KNOCKOUT; NEURONS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-FOS; RECEPTOR, MELATONIN, MT1; RECEPTOR, MELATONIN, MT2; SIGNAL TRANSDUCTION;

EPICOCCUM; MAMMALIA; MUS;

EID: 48949100382     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.06.082     Document Type: Article

References (29)

1. Al-Ghoul W.M., Herman M.D., and Dubocovich M.L. Melatonin receptor subtype expression in human cerebellum. NeuroReport 9 (1998) 4063-4068
2. Ayoub M.A., Couturier C., Lucas-Meunier E., Angers S., Fossier P., Bouvier M., and Jockers R. Monitoring of ligand-independent dimerization and ligand-induced conformational changes of melatonin receptors in living cells by bioluminescence resonance energy transfer. J. Biol. Chem. 277 (2002) 21522-21528
3. Ayoub M.A., Levoye A., Delagrange P., and Jockers R. Preferential formation of MT1/MT2 melatonin receptor heterodimers with distinct ligand interaction properties compared with MT2 homodimers. Mol. Pharmacol. 66 (2004) 312-321
4. Bordt S.L., McKeon R.M., Li P.K., Witt-Enderby P.A., and Melan M.A. N1E-115 mouse neuroblastoma cells express MT1 melatonin receptors and produce neurites in response to melatonin. Biochim. Biophys. Acta 1499 (2001) 257-264
5. Brunner P., Sozer-Topcular N., Jockers R., Ravid R., Angeloni D., Fraschini F., Eckert A., Muller-Spahn F., and Savaskan E. Pineal and cortical melatonin receptors MT1 and MT2 are decreased in Alzheimer's disease. Eur. J. Histochem. 50 (2006) 311-316
6. Chan A.S., Lai F.P., Lo R.K., Voyno-Yasenetskaya T.A., Stanbridge E.J., and Wong Y.H. Melatonin mt1 and MT2 receptors stimulate c-Jun N-terminal kinase via pertussis toxin-sensitive and -insensitive G proteins. Cell Signal. 14 (2002) 249-257
7. Cui P., Yu M., Luo Z., Dai M., Han J., Xiu R., and Yang Z. Intracellular signaling pathways involved in cell growth inhibition of human umbilical vein endothelial cells by melatonin. J. Pineal Res. 44 (2008) 107-114
8. Dubocovich M.L., Rivera-Bermudez M.A., Gerdin M.J., and Masana M.I. Molecular pharmacology, regulation and function of mammalian melatonin receptors. Front. Biosci. 8 (2003) d1093-d1108
9. Gabellini N., Manev R.M., and Manev H. Is the heterologous expression of metabotropic glutamate receptors (mGluRs) an appropriate method to study the mGluR function? Experience with human embryonic kidney 293 cells transfected with mGluR1. Neurochem. Int. 24 (1994) 533-539
10. Giusti P., Gusella M., Lipartiti M., Milani D., Zhu W., Vicini S., and Manev H. Melatonin protects primary cultures from kainite but not from N-methyl-d-aspartate excitotoxicity. Exp. Neurol. 131 (1995) 39-46
11. Jimenez-Jorge S., Guerrero J.M., Jimenez-Caliani J., Naranjo M.C., Lardone P.J., Carrillo-Vico A., Osuna C., and Molinero P. Evidence for melatonin synthesis in the rat brain during development. J. Pineal Res. 42 (2007) 240-246
12. Kato K., Hirai K., Nishiyama K., Uchikawa O., Fukatsu K., Ohkawa S., Kawamata Y., Hinuma S., and Miyamoto M. Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist. Neuropharmacology 48 (2005) 301-310
13. Kilic U., Kilic E., Reiter R.J., Bassetti C.L., and Hermann D.M. Signal transduction pathways involved in melatonin-induced neuroprotection after focal cerebral ischemia in mice. J. Pineal Res. 38 (2005) 67-71
14. Larson J., Jessen R.E., Uz T., Arslan A.D., Kurtuncu M., Imbesi M., and Manev H. Impaired hippocampal long-term potentiation in melatonin MT2 receptor-deficient mice. Neurosci. Lett. 393 (2006) 23-26
15. Pääkkönen T., Mäkinen T.M., Leppäluoto J., Vakkuri O., Rintamäki H., Palinkas L.A., and Hassi J. Urinary melatonin: a noninvasive method to follow human pineal function as studied in three experimental conditions. J. Pineal Res. 40 (2006) 110-115
16. Petit L., Lacroix I., de Coppet P., Strosberg A.D., and Jockers R. Differential signaling of human Mel1a and Mel1b melatonin receptors through the cyclic guanosine 3¢-5¢-monophosphate pathway. Biochem. Pharmacol. 58 (1999) 633-639
17. Radio N.M., Doctor J.S., and Witt-Enderby P.A. Melatonin enhances alkaline phosphatase activity in differentiating human adult mesenchymal stem cells grown in osteogenic medium via MT2 melatonin receptors and the MEK/ERK (1/2) signaling cascade. J. Pineal Res. 40 (2006) 332-342
18. Rousseau A., Petrén S., Plannthin J., Eklundh T., and Nordin C. Serum and cerebrospinal fluid concentrations of melatonin: a pilot study in healthy male volunteers. J. Neural Transm. 106 (1999) 883-888
19. Savaskan E., Olivieri G., Meier F., Brydon L., Jockers R., Ravid R., Wirz-Justice A., and Muller-Spahn F. Increased melatonin 1a-receptor immunoreactivity in the hippocampus of Alzheimer's disease patients. J. Pineal Res. 32 (2002) 59-62
20. Savaskan E., Ayoub M.A., Ravid R., Angeloni D., Fraschini F., Meier F., Eckert A., Muller-Spahn F., and Jockers R. Reduced hippocampal MT2 melatonin receptor expression in Alzheimer's disease. J. Pineal Res. 38 (2005) 10-16
21. Sumaya I.C., Masana M.I., and Dubocovich M.L. The antidepressant-like effect of the melatonin receptor ligand luzindole in mice during forced swimming requires expression of MT2 but not MT1 melatonin receptors. J. Pineal Res. 39 (2005) 170-177
22. Thomas L., Purvis C.C., Drew J.E., Abramovich D.R., and Williams L.M. Melatonin receptors in human fetal brain: 2-[(125)I]iodomelatonin binding and MT1 gene expression. J. Pineal Res. 33 (2002) 218-224
23. Uz T., Giusti P., Franceschini D., Kharlamov A., and Manev H. Protective effect of melatonin against hippocampal DNA damage induced by administration of kainate to rats. Neuroscience 73 (1996) 631-636
24. Uz T., Manev R., and Manev H. 5-Lipoxygenase is required for proliferation of immature cerebellar granule neurons in vitro. Eur. J. Pharmacol. 418 (2001) 15-22
25. Uz T., Arslan A.D., Kurtuncu M., Imbesi M., Akhisaroglu M., Dwivedi Y., Pandey G.N., and Manev H. The regional and cellular expression profile of the melatonin receptor MT1 in the central dopaminergic system. Brain Res. Mol. Brain Res. 136 (2005) 45-53
26. Witt-Enderby P.A., Masana M.I., and Dubocovich M.L. Physiological exposure to melatonin supersensitizes the cyclic adenosine 3¢,5¢-monophosphate-dependent signal transduction cascade in Chinese hamster ovary cells expressing the human mt1 melatonin receptor. Endocrinology 139 (1998) 3064-3071
27. Witt-Enderby P.A., Radio N.M., Doctor J.S., and Davis V.L. Therapeutic treatments potentially mediated by melatonin receptors: potential clinical uses in the prevention of osteoporosis, cancer and as an adjuvant therapy. J. Pineal Res. 41 (2006) 297-305
28. Wu Y.H., Zhou J.N., Balesar R., Unmehopa U., Bao A., Jockers R., Van Heerikhuize J., and Swaab D.F. Distribution of MT1 melatonin receptor immunoreactivity in the human hypothalamus and pituitary gland: colocalization of MT1 with vasopressin, oxytocin, and corticotrophin-releasing hormone. J. Comp. Neurol. 499 (2006) 897-910
29. Wu Y.H., Zhou J.N., Van Heerikhuize J., Jockers R., and Swaab D.F. Decreased MT1 melatonin receptor expression in the suprachiasmatic nucleus in aging and Alzheimer's disease. Neurobiol. Aging 28 (2007) 1239-1247